MARKET

ENOB

ENOB

Enochian Biosciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.75
+0.05
+0.88%
Opening 10:05 09/18 EDT
OPEN
5.74
PREV CLOSE
5.70
HIGH
5.75
LOW
5.74
VOLUME
2.40K
TURNOVER
--
52 WEEK HIGH
9.50
52 WEEK LOW
4.050
MARKET CAP
223.04M
P/E (TTM)
-6.9748
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ENOB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

ENOB News

  • 71 Biggest Movers From Yesterday
  • Benzinga.6d ago
  • Mid-Afternoon Market Update: Dow Rises Over 100 Points; Zscaler Shares Tumble On Weak Earnings Guidance
  • Benzinga.6d ago
  • The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
  • Benzinga.08/06 11:22
  • Enochian BioSciences Inventor Named to Two Important Scientific Committees
  • GlobeNewswire.06/03 12:00

More

Industry

Biotechnology & Medical Research
-0.82%
Pharmaceuticals & Medical Research
-0.33%

Hot Stocks

Name
Price
%Change

About ENOB

Enochian Biosciences Inc, formerly DanDrit Biotech USA, Inc., is a Denmark-based biotechnology company. The Company focuses on developing vaccine against colorectal cancer. It has developed various vaccines that are used in various clinical trials in Europe and Asia, including MelCancerVac (MCV) for treatment of cancer (one phase I/II trial in Denmark and two phase II trials in Denmark and Singapore), Tolerogenic (producing immunologic tolerance) dendritic cell (TDC) (pre-clinical stage in Denmark), and Melvaccine (MV), a melanoma cell lysate used as standalone vaccine (pre-clinical state in Denmark). The Company offers MCV platform technology, which is a cellular immunotherapy for treatment of cancer. Also, the Company develops gene therapies for patients with human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS).
More

Webull offers Enochian Biosciences Inc (ENOB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.